Why Albemarle Corporation (ALB) stock moved
Albemarle Corporation (ALB) shares fell 2.1% to $118.20 as of July 21, 2026, a modest decline from the prior close of $120.78. BestStocks flagged the session as a major change for ALB. No single company-specific catalyst was confirmed during the move window. Below, we break down what changed for ALB, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
ALB fell 2.1% to $118.20
Albemarle Corporation (ALB) moved -2.14% from $120.78 to $118.20 on 2026-07-20. We checked news, earnings, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The move appears to be technical, with ALB reaching a new 30-day low on volume near its 5-day average. Monitor whether ALB holds above $118.20 or tests lower support levels in the coming sessions.
What it means for Albemarle Corporation investors
For Albemarle Corporation investors, the recent signals add up to a bearish shift. Weighing against that: Negative session, down 2.1%; New SEC filing — review for material disclosures. Wall Street's consensus price target sits at $206.77, implying +74.9% upside from $118.20. Over the past 90 days analysts logged 1 upgrade and 0 downgrades. BestStocks rates the overall signal quality weak (0/100). With earnings roughly 15 days out, the next report is the most likely near-term test of the move.
ALB price reaction
ALB last traded at $118.20, down $2.58 (-2.14%) from the previous close of $120.78. The session traded on 0.8× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $118.20 and $156.69, and it currently sits about 0% of the way up that band.
Bullish and bearish analyst opinions on Albemarle Corporation (ALB)
The consensus analyst price target on Albemarle Corporation (ALB) is $206.77, 74.9% above the recent $118.20. Over the past 90 days analysts logged 1 upgrade, 12 maintains, and 0 downgrades. Here is how the bullish and bearish cases on ALB line up.
The bullish case
- Wall Street's consensus price target of $206.77 implies +74.9% upside from $118.20.
- The Street's most bullish target is $264.00 (+123.4%).
- 1 analyst upgrade in the past 90 days, most recently Citigroup to Buy (2026-06-18).
The bearish case
- Negative session, down 2.1%.
- Albemarle Corporation (ALB) moved -4.23% from $124.74 to $119.46 on 2026-07-16.
Weighing both sides, BestStocks' composite read of recent signals is bearish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Jul 21, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for ALB
Frequently asked questions about ALB
Why did Albemarle Corporation (ALB) stock move?
ALB fell 2.1% to $118.20. No single company-specific catalyst was confirmed during the move window, and it looks technical.
How much did ALB stock fall?
ALB lost 2.14% ($2.58) versus the prior close of $120.78, last trading at $118.20 on 0.8× average volume.
When is Albemarle Corporation's next earnings date?
ALB's next earnings report is estimated for 2026-08-05 — about 15 days away.
What is the analyst price target for ALB?
The consensus analyst price target for ALB is $206.77, about 74.9% above the current $118.20. Over the past 90 days, analysts recorded 1 upgrade, 12 maintains, and 0 downgrades.
How BestStocks tracks ALB
This page is generated automatically by BestStocks' change-detection system after its price and volume cleared ALB-specific materiality thresholds, triggering an evidence check. It draws on 8 tracked change events for ALB, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of July 21, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.